SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-010726
Filing Date
2020-02-19
Accepted
2020-02-19 17:31:40
Documents
2
Period of Report
2020-02-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1467
2 POA DOCUMENT poa.txt EX-24.3_896134 4031
  Complete submission text file 0001209191-20-010726.txt   6970
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Issuer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ROIVANT SCIENCES, INC. 320 WEST 37TH STREET, 6TH FLOOR NEW YORK NY 10018
Business Address
Venker Eric (Reporting) CIK: 0001801917 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38906 | Film No.: 20631394